Eupraxia Pharmaceuticals Inc. (EPRX)
NASDAQ: EPRXHealth CarePharmaceuticals and BiotechnologyUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
After hours: 7.78 0.00%
EPRX stock chart
Technical analysisKey statistics
All statistics- Market cap
- $514.05M
- EPS (TTM)
- -$1.02
- Dividend yield
- None
- 52-week range
- 5.25 – 9.32
- Day range
- 7.48 – 7.88
- Volume / Avg
- 853.31K / 558.37K
- Beta
- —
- Shares outstanding
- 66.07M
- Next earnings
- Nov 3, 2026
52-week range
EPRX stock today
Shares of Eupraxia Pharmaceuticals (EPRX) finished higher on Oct 7 at $7.78, a gain of 0.52% or $0.04 per share, versus the S&P 500's 0.22% decline. Shares are 16.5% below their 52-week high of $9.32, set on Jan 21, 2026 and 48.2% above the 52-week low of $5.25, in the middle of the past year's range. EPRX is up 3.0% year to date, underperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has gained 29.2%.
Eupraxia Pharmaceuticals has posted a net loss over the last twelve months (EPS of -$1.02), so its P/E ratio is not meaningful. Eupraxia Pharmaceuticals's next earnings report is expected on Nov 3, 2026.
Summary generated from market data by MetaCap's automated system. Methodology
About Eupraxia Pharmaceuticals
Company profile- Sector
- Health Care
- Industry
- Pharmaceuticals and Biotechnology
Earnings
Earnings history- Next report
- Nov 3, 2026
- EPS estimate
- $-0.26
Indexes, lists and sector
Eupraxia Pharmaceuticals stock FAQ
What is Eupraxia Pharmaceuticals's stock price today?
EPRX last traded at $7.78 as of Oct 7, 4:00 PM EDT, up 0.52% on the day. Prices are delayed at least 15 minutes.
When is Eupraxia Pharmaceuticals's next earnings date?
Eupraxia Pharmaceuticals is expected to report earnings on Tuesday, November 3, 2026. Analysts expect EPS of $-0.26.
What is the EPRX 52-week high?
The 52-week high for EPRX is $9.32 and the 52-week low is $5.25. The stock is currently 16.5% below its high.